NCT05634200

Brief Summary

Conflicting evidence exist in the literature on the utility of bronchoscopy in patients with haemoptysis and negative/non-diagnostic chest CT scan. The primary aim of this prospective, observational, multicenter study is to evaluate the utility of bronchoscopy in patients with haemoptysis and negative/non-diagnostic CT scans. Secondary aims are related to the utility of bronchoscopy to detect occult malignancies, the source of the bleeding and the clinical features of the cohort

Trial Health

60
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Oct 2022

Typical duration for all trials

Geographic Reach
2 countries

14 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2022

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

November 21, 2022

Completed
11 days until next milestone

First Posted

Study publicly available on registry

December 2, 2022

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2024

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2025

Completed
Last Updated

August 21, 2024

Status Verified

August 1, 2024

Enrollment Period

2 years

First QC Date

November 21, 2022

Last Update Submit

August 19, 2024

Conditions

Keywords

Computed tomographyBronchoscopyLung cancerCT scanHaemoptysis

Outcome Measures

Primary Outcomes (1)

  • To evaluate the proportion of patients with haemoptysis and negative/non-diagnostic CT scans in whom bronchoscopy allows an aetiological (i.e., endoscopic and/or microbiological and/or anatomopathological) diagnosis

    The primary aim of the study is to evaluate the proportion of patients with haemoptysis and negative/non-diagnostic CT scans in whom bronchoscopy allows an aetiological (i.e., endoscopic and/or microbiological and/or anatomopathological) diagnosis

    One year

Secondary Outcomes (6)

  • To evaluate the proportion of patients in whom bronchoscopy may detect occult endobronchial neoplasms (not detected with chest CT scan)

    One year

  • To evaluate the proportion of patients in whom bronchoscopy may identify the source of the bleeding

    One year

  • To evaluate the proportion of patients with haemoptysis and negative chest CT scan in whom bronchoscopic findings may induce variation in the treatment of the patients

    One year

  • To evaluate the proportion of patients with a negative bronchoscopy at baseline, in whom a an endoscopic examination performed during the follow-up for recurrent haemoptysis may allow an aetiological diagnosis

    One year

  • To evaluate the proportion of patients with a negative chest CT scan and bronchoscopy in whom lung cancer may be diagnosed during the follow-up

    One year

  • +1 more secondary outcomes

Study Arms (1)

Patients with haemoptysis and negative/non-diagnostic CT scan

Patients with haemoptysis and negative/non-diagnostic CT scan (i.e. with focal peripheral lung fibrosis, calcified parenchymal nodules with a maximum diameter \<5 mm, linear subsegmental atelectasis, hilar-mediastinal lymph nodes with a short axis \<1 cm, pleural thickening/pleural calcification and focal area of emphysema with a diameter \<1 cm) for whom bronchoscopy is deemed necessary to obtain an aetiological diagnosis.

Procedure: Bronchoscopy

Interventions

BronchoscopyPROCEDURE

During bronchoscopy endobronchial biopsy, transbronchial biopsy, transbronchial needle aspiration, bronchial washing, bronchoalveolar lavage, EBUS-TBNA and EUS-B-FNA may be performed

Patients with haemoptysis and negative/non-diagnostic CT scan

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients (i.e., ≥18 years) of any nationality (inpatients and outpatients) with haemoptysis of unknown aetiology and negative chest CT scan/with CT scan showing non-diagnostic findings (i.e. focal peripheral lung fibrosis, calcified parenchymal nodules with a maximum diameter \<5 mm, linear subsegmental atelectasis, hilar-mediastinal lymph nodes with a short axis \<1 cm, pleural thickening/pleural calcification and focal area of emphysema with a diameter \<1 cm), in whom bronchoscopy is deemed necessary to obtain an aetiological diagnosis.

You may qualify if:

  • ≥18 years old
  • Haemoptysis of unknown origin
  • Negative or non-diagnostic chest CT scan

You may not qualify if:

  • Known bleeding lesions of the upper or lower respiratory airways
  • Chest CT scan diagnostic for hemoptysis etiology
  • Refusal to sign the informed consent
  • Refusal of bronchoscopy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (14)

- Respiratory Unit, ASST Papa Giovanni XVIII

Bergamo, Italy

RECRUITING

- Interventional Pulmonology Unit, Policlinico S. Orsola-Malpighi

Bologna, Italy

RECRUITING

Department of Pulmonary and Critical Care Medicine, Sant'Anna Hospital

Como, Italy

RECRUITING

Respiratory Unit, ASST Lodi

Lodi, Italy

RECRUITING

Respiratory Unit, ASST Santi Paolo e Carlo

Milan, 20142, Italy

RECRUITING

- Respiratory Unit, Sacco Hospital, ASST Fatebenefratelli-Sacco

Milan, Italy

RECRUITING

Respiratory Unit, San Gerardo Hospital, ASST Monza

Monza, Italy

RECRUITING

Interventional Pulmonology Unit, Dept of Pulmonology, Oncology and Hematology, Cardarelli Hospital

Naples, Italy

RECRUITING

- Respiratory Unit, IRCCS Foundation Policlinico San Matteo

Pavia, Italy

ACTIVE NOT RECRUITING

Pulmonology Unit, Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia

Reggio Emilia, Italy

RECRUITING

- Interventional Pulmonology Unit, Policlinico Agostino Gemelli

Roma, Italy

RECRUITING

- Respiratory Unit, A.O.U. Città della Salute e della Scienza di Torino

Torino, Italy

RECRUITING

Department of Pulmonology, University Hospital of Udine (ASUFC)

Udine, Italy

RECRUITING

Interventional Pulmonology Unit, Respiratory Department, University Hospital Santa Creu i Sant Pau

Barcelona, Spain

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

blood, serum, bronchial/lung tissue, bronchial secretions, BAL fluid, lymph node aspirates

MeSH Terms

Conditions

HemoptysisLung Neoplasms

Interventions

Bronchoscopy

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract DiseasesHemorrhagePathologic ProcessesPathological Conditions, Signs and SymptomsSigns and Symptoms, RespiratorySigns and SymptomsRespiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasms

Intervention Hierarchy (Ancestors)

Diagnostic Techniques, Respiratory SystemDiagnostic Techniques and ProceduresDiagnosisEndoscopyDiagnostic Techniques, SurgicalMinimally Invasive Surgical ProceduresSurgical Procedures, OperativePulmonary Surgical ProceduresThoracic Surgical Procedures

Study Officials

  • Michele Mondoni, MD

    Respiratory Unit, ASST Santi Paolo e Carlo, San Paolo Hospital, Milan

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Respiratory Medicine

Study Record Dates

First Submitted

November 21, 2022

First Posted

December 2, 2022

Study Start

October 1, 2022

Primary Completion

October 1, 2024

Study Completion

October 1, 2025

Last Updated

August 21, 2024

Record last verified: 2024-08

Locations